Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a condition that affects people who have recovered from COVID-19 but continue to experience symptoms for weeks or months after the initial illness. The symptoms of long COVID are wide-ranging and can affect different parts of the body, including the respiratory, cardiovascular, neurological, and musculoskeletal systems. One of the musculoskeletal symptoms that have been reported in some long COVID patients is fibromyalgia.
Fibromyalgia is a chronic pain condition that affects the muscles, tendons, and ligaments. It is characterized by widespread pain, fatigue, sleep disturbances, and cognitive difficulties. The exact cause of fibromyalgia is unknown, but it is believed to be related to abnormal processing of pain signals in the central nervous system. Fibromyalgia can be triggered by physical or emotional trauma, infections, or other medical conditions. Some studies suggest that COVID-19 infection may also be a trigger for fibromyalgia, particularly in patients with long COVID.
Understanding Long Covid
Long Covid, also known as post-Covid syndrome, refers to the persistence of Covid-19 symptoms beyond the acute phase of the illness. This condition is experienced by a significant number of Covid-19 patients, and it has been reported to affect people of all ages and backgrounds.
Long Covid is not yet fully understood, and its mechanisms are still being studied. However, it is believed to be caused by the persistence of the SARS-CoV-2 virus in the body, which triggers an overactive immune response and leads to chronic inflammation. This inflammation can affect various organs and systems in the body, leading to a wide range of symptoms.
Fibromyalgia patients who develop Long Covid may experience a worsening of their symptoms, as the persistent inflammation can trigger fibromyalgia flare-ups. Additionally, the stress and anxiety associated with Long Covid can exacerbate fibromyalgia symptoms, leading to a vicious cycle of pain and discomfort.
The symptoms of Long Covid can vary widely, and they can affect different parts of the body. Some common symptoms include fatigue, brain fog, shortness of breath, chest pain, joint pain, muscle weakness, and sleep disturbances. These symptoms can persist for weeks or months after the acute phase of Covid-19 has passed, and they can significantly impact the quality of life of affected individuals.
It is important to note that Long Covid is not limited to individuals who had severe Covid-19 symptoms during the acute phase of the illness. Even people who had mild or asymptomatic Covid-19 can develop Long Covid, and the severity and duration of the symptoms can vary widely.
Overall, Long Covid is a complex and poorly understood condition that can significantly impact the health and well-being of affected individuals. Fibromyalgia patients who develop Long Covid may experience a worsening of their symptoms, and it is important for healthcare providers to be aware of this potential complication and provide appropriate support and treatment.
The Intersection of Long Covid and Fibromyalgia
Long Covid and fibromyalgia are two distinct conditions with overlapping symptoms. However, recent studies have shown that Long Covid can exacerbate fibromyalgia symptoms, leading to a condition known as fibrocovid.
Fibromyalgia is a chronic pain condition that affects millions of people worldwide. The condition is characterized by widespread pain, fatigue, and sleep disturbances. Long Covid, on the other hand, is a condition that affects people who have recovered from Covid-19 but continue to experience symptoms for an extended period.
One of the most common symptoms of Long Covid is fatigue, which is also a hallmark symptom of fibromyalgia. Studies have shown that Long Covid can worsen fatigue in fibromyalgia patients, leading to a condition known as post-Covid fibromyalgia.
In addition to fatigue, Long Covid can also worsen pain and inflammation in fibromyalgia patients. Muscle pain, headaches, and cognitive dysfunction are other symptoms that can be exacerbated by Long Covid in fibromyalgia patients.
Sleep disturbance is another common symptom of both Long Covid and fibromyalgia. Long Covid can worsen sleep disturbance in fibromyalgia patients, leading to a vicious cycle of pain and fatigue.
Dyspnea, nausea, and arthralgia are other symptoms that can be worsened by Long Covid in fibromyalgia patients. Flares of fibromyalgia symptoms can also be triggered by Long Covid.
In summary, Long Covid can exacerbate fibromyalgia symptoms, leading to a condition known as fibrocovid. Fibrocovid is a relatively new concept, and more research is needed to understand the relationship between Long Covid and fibromyalgia fully. However, it is clear that Long Covid can have a significant impact on fibromyalgia patients, worsening their symptoms and reducing their quality of life.
Prevalence and Severity of FibroCOVID
FibroCOVID is a new entity that has emerged due to the high prevalence of fibromyalgia (FM) in patients with long COVID-19. According to a cross-sectional survey, the estimated prevalence of FM in patients with long COVID-19 is over 30%. This suggests that long COVID-19 may be a risk factor for developing FM.
The severity of symptoms in patients with FibroCOVID is also a concern. A study found that the severity of the Combined Index of Severity in Fibromyalgia (ICAF) was significantly higher in patients with FibroCOVID than in patients with FM alone. This suggests that the symptoms of FibroCOVID may be more severe than those of FM.
Symptom severity scales are commonly used to assess the severity of FM symptoms. However, there is currently no specific symptom severity scale for FibroCOVID. Nevertheless, studies have shown that the symptoms of FibroCOVID are similar to those of FM, including widespread pain, fatigue, and cognitive dysfunction.
The severity of symptoms in patients with FibroCOVID is a concern, as they may be more severe than those of FM alone. While there is no specific symptom severity scale for FibroCOVID, studies have shown that the symptoms are similar to those of FM.
Risk Factors for FibroCOVID
Several factors increase the risk of developing FibroCOVID. According to a web-based survey, age, female gender, and a history of anxiety and depression represent the strongest risk factors for post-COVID-19 Fibromyalgia. The survey also found that patients with FibroCOVID were more likely to have experienced severe COVID-19 symptoms.
Another study found that patients with autoimmune rheumatic diseases (ARDs) who develop long COVID are at high risk of developing FibroCOVID. The study identified obesity, fatigue, and anxiety as the strongest risk factors for FibroCOVID in patients with ARDs.
Stress is another risk factor for FibroCOVID. A study found that patients who experienced stress during the COVID-19 pandemic were more likely to develop FibroCOVID. The study also found that patients with FibroCOVID had higher levels of anxiety and depression.
Physiological Mechanisms Behind Fibrocovid
Pathogens such as viruses can cause damage to organs and tissues in the body. COVID-19 is known to cause damage to the lungs, heart, and brain. This damage can lead to long-term complications such as Fibromyalgia. The mechanisms behind the development of Fibromyalgia in Long COVID patients are not entirely clear, but researchers believe that multiple factors are involved.
The nervous system is one of the key players in the development of Fibromyalgia. Neuroinflammation, which is the inflammation of nerve cells, is a common feature of Fibromyalgia. Long COVID patients may experience chronic fatigue syndrome (ME/CFS), which is characterized by fatigue, pain, and cognitive dysfunction. ME/CFS and Fibromyalgia share similar symptoms, and some researchers believe that they may have a common pathogenesis.
The immune system is also involved in the development of Fibromyalgia. Immune activation and autoimmunity have been implicated in the pathogenesis of Fibromyalgia. Long COVID patients may experience immune dysregulation, which can lead to the development of Fibromyalgia. Inflammatory cytokines, which are proteins involved in the immune response, have been shown to be elevated in Fibromyalgia patients.
Another possible mechanism behind the development of Fibromyalgia in Long COVID patients is small fiber neuropathy. Small fiber neuropathy is a condition that affects the small nerve fibers in the skin and other organs. It can cause symptoms such as pain, numbness, and tingling. Small fiber neuropathy has been linked to Fibromyalgia, and Long COVID patients may be at an increased risk of developing small fiber neuropathy.
Management and Rehabilitation of Fibrocovid
To manage and rehabilitate Fibrocovid, a multidisciplinary approach is required, including physical therapy, cognitive-behavioral therapy, and pharmacological intervention.
Rehabilitation plays a crucial role in managing Fibrocovid. Physical therapy can help alleviate symptoms such as pain, fatigue, and weakness. The therapy can include aerobic exercise, stretching, and resistance training. Patients with Fibrocovid may also benefit from cognitive-behavioral therapy, which can help patients manage their symptoms and improve their quality of life.
Sleep problems and insomnia are common in patients with Fibrocovid. Centers for Disease Control and Prevention (CDC) recommends that patients with long COVID-19 should seek medical attention if they experience sleep problems or insomnia. Italian researchers have also suggested that cognitive-behavioral therapy can help improve sleep quality in patients with Fibrocovid.
Pharmacological intervention can also be used to manage Fibrocovid. RMD Open: Rheumatic & Musculoskeletal Diseases published a study that suggests that patients hospitalized with COVID-19 who received dexamethasone had a lower incidence of post-COVID-19 fibromyalgia.
Long COVID has been a topic of interest for researchers since its emergence. Researchers have been trying to understand the effects of long COVID on individuals with pre-existing conditions such as fibromyalgia.
The available literature suggests that long COVID can potentially worsen the symptoms of fibromyalgia. A prospective observational study conducted in Italy found that the prolonged lockdown imposed during the COVID-19 pandemic had a variable impact on the well-being of patients with fibromyalgia. The study found that mixed effects of prolonged lockdown on the well-being of patients were observed.
Another study found that people with fibromyalgia present abnormal levels of stress reactivity linked to functional impairment. Coping with fibromyalgia during the COVID-19 pandemic can be challenging for individuals with the condition.
However, it is important to note that the available literature on the effects of long COVID on fibromyalgia is limited. Further research is needed to understand the long-term effects of long COVID on fibromyalgia.
In conclusion, while the available literature suggests that long COVID can potentially worsen the symptoms of fibromyalgia, further research is needed to understand the long-term effects of long COVID on fibromyalgia.
Fialho MFP, Brum ES, Oliveira SM. Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Inflammopharmacology. 2023 Apr;31(2):633-651. doi: 10.1007/s10787-023-01160-w. Epub 2023 Feb 27. PMID: 36849853; PMCID: PMC9970139.
Plaut S. “Long COVID-19” and viral “fibromyalgia-ness”: Suggesting a mechanistic role for fascial myofibroblasts (Nineveh, the shadow is in the fascia). Front Med (Lausanne). 2023 Apr 6;10:952278. doi: 10.3389/fmed.2023.952278. PMID: 37089610; PMCID: PMC10117846.
Vittorio Schweiger, Erica Secchettin, Giovanni Perini, Alvise Martini, Katia Donadello, Leonardo Gottin, Giovanna Del Balzo, Giustino Varrassi, Enrico Polati. Quality of life and psychological assessment in patients with Fibromyalgia Syndrome during COVID-19 pandemic in Italy: prospective observational study. Signa Vitae. 2022. 18(1);41-46.